NASDAQ

Corvus Pharmaceuticals, Inc. (CRVS)

♥ 419 Thanks from members

Live price chart, market sentiment, and community perspectives for Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Corvus Pharmaceuticals ScientistsLeadership: Richard A. Miller (CEO)Leadership: Taiyin YangHolder: Baker Bros. AdvisorsHolder: Fidelity Management and ResearchHolder: BlackRock, Inc.SoquelitinabCifnetantImmunology Pipeline#CRVS stock#Corvus Pharmaceuticals#clinical stage biotech#NASDAQ CRVS#cancer immunotherapy